Gregorio Barilà

14PUBLICATIONS
76CO-AUTHORS
Haematological tumoursPredictive and prognostic markersAutoimmunityGene and molecular therapyCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 18, 2026
Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

|Aug 13, 2026
Gene Expression, Non-Coding RNA, and Circular RNA Alterations in Patients with T-Prolymphocytic Leukemia.

|Jun 18, 2026
Vaccination and Antiviral Combination Improves Resolution Time of COVID-19 Infection in Treated Multiple Myeloma: A Retrospective Study.

|Jun 26, 2025
NK-type large granular lymphocyte leukemia comes of age.

Gianpietro Semenzato, Antonella Teramo, Gregorio Barilà

|Mar 19, 2025
Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab-, Elotuzumab-, and Carfilzomib-Based Triplet Regimens: A Multicenter Real-World Analysis of 635 Patients.

Fortunato Morabito, Enrica Antonia Martino, Monica Galli

|May 31, 2024
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials.

Enrica Antonia Martino, Salvatore Palmieri, Monica Galli

Pageof 3

Frequent Collaborators

6 joint publications

Gianpietro Semenzato

5 joint publications

Vanessa Rebecca Gasparini

5 joint publications

Renato Zambello

4 joint publications

Antonella Teramo